Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats

Journal of Nutritional Science and Vitaminology

Volumn 48, Issue 5, 2002, Pages 420-422

  Ohtsuki, Kazumasa ^a   Abe, Asaki ^a   Mitsuzumi, Hitoshi ^b   Kondo, Masaru ^a   Uemura, Kanae ^a   Iwasaki, Yumiko ^a   Kondo, Yasuhiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Blood pressure; Hesperidin; Hypertension; Long term administration

Indexed keywords

GLUCOSYLHESPERIDIN; HESPERIDIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIETARY INTAKE; HEART RATE; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALIA; CITRUS;

EID: 0036825391     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.48.420     Document Type: Article

References (14)

1. Miyake Y, Yamamoto K, Tsujihara N, Osawa T. 1998. Protective effects of lemon flavonoids on oxidative stress in diabetic rat. Lipids 33: 689-695.
2. Fraga CG, Martino VS, Ferraro GE, Coussio JD, Boveris A. 1987. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol 36: 717-720.
3. Lee TP, Matteliano ML, Middleton E Jr. 1982. Effects of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipids metabolism. Life Sci 31: 2765-2774.
4. Sekiya K, Okuda H. 1982. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 105: 1090-1095.
5. Havsteen B. 1983. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32: 1141-1148.
6. Struckmann JR, Nicolaides AN. 1994. Flavonoids a review of the pharmacology and therapeutic efficacy of daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology 45: 419-428.
7. Galati EM, Trovato A, Kirjavainen S, Forestieri AM, Rossitto A, Monforte MT. 1996. Biological effects of hesperidin, a citrus flavonoid, (note III): Antihypertensive and diuretic activity in rat. Il Pharmaco 51: 219-221.
8. Machida K, Ueda T, Sato T, Osawa K, Andoh R, Hisamichi S. 1985. Studies on the constituents of citrus hassaku Hort. ex Tanaka (1). On the structure and hypotensive effects of flavonoid glycosides in citrus hassaku peelings. Tohoku Yakka Daigaku Kenkyu Nempo (Annu Rep Tohoku Coll Pharmacy) 32: 135-142.
9. Hijiya H, Miyake T. 1991. Alpha-Glycosyl Hesperidin, and Its Preparation and Uses. European Patent Publication No 0402049.
10. Nikaido T, Ohmoto T, Kinoshita T, Sankawa U, Monache FD, Botta B, Tomimori T, Miyaichi Y, Shirataki Y, Yokoe I, Komatsu M. 1989. Inhibition of adenosine 3′.5′-cyclic monophosphate phosphodiesterase by flavonoids. III. Chem Pharm Bull 37: 1392-1395.
11. Chen QM, Feng GH. 1984. Vasodilating action of methylhesperidin. Acta Pharrnacol Sinica 8: 344-348.
12. Emim JA, Oliveira AB, Lapa AJ. 1994. Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J Pharm Pharmacol 46: 118-122.
13. Carr A, Frei B. 2000. The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med 28: 1806-1814.
14. Hodis HN, Mack WJ, LaBree L, Cashin-Hemphil L, Sevanian A, Johnson R, Azen SP 1995. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273: 1849-1854.